Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Long-acting Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning
    Release Date:
    Partner:

    Lilly

    Review Process: Pfizer Internal
    Education Internal Medicine All
    NASH – Future of Non-invasive Diagnosis Technologies
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)
    Release Date:
    Partner:

    International Society for Infectious Diseases (ISID)

    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Advances in Oncology Therapy in Renal Cell Carcinoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region
    Release Date:
    Partner:

    RCNi (subsidiary of the Royal College of Nursing)

    Review Process: Pfizer Internal
    Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Argentina, Brazil, Chile, Colombia
    Vaccine Preventable Diseases – COVID-19 (closed early)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All